Contact number
+852 2219 0888Chambers Review
Hogan Lovells has a respected Asia-wide practice with an established presence in China and Japan. The team is capable of advising companies across the spectrum of life sciences issues, with expertise in the fields of commercial agreements, product liability, disputes, investigations and compliance. Hogan Lovells is known for its work on IP protection and enforcement, cross-border transactions and FDI matters and handles work for a strong roster of leading global pharmaceutical, medical device and biotech companies. The firm also boasts capable corporate M&A expertise to bolster its life sciences offering.
Tokyo-based Frederick Ch'en is a main contact for the firm's Japan life sciences practice and Wei Jun is the China-based key contact.
Work Highlights
- Hogan Lovellsadvised Sinopharm, a consortium comprising state-owned investors and led by Sinopharm Group Hong Kong, on making a pre-conditional proposal to privatise China Traditional Chinese Medicine.
Strengths
Provided by Chambers
"All members of the team that I worked with showed consistent high legal capabilities, in-depth technical knowledge, and superb communication skills."
"The firm has specialists in each area and provides appropriate service. The lawyers are responsive and meticulous in organising issues and proposing solutions."
"All members of the team that I worked with showed consistent high legal capabilities, in-depth technical knowledge, and superb communication skills."
"The firm has specialists in each area and provides appropriate service. The lawyers are responsive and meticulous in organising issues and proposing solutions."